RESUMEN
Skin aging is the most apparent form of senescence and could reflect the aging of inner organs. Molecular changes involved in innate immunity signaling, tumorigenesis, and inflammation were studied. Protein levels were evaluated based on the immunohistochemistry of the skin of 42 young and old individuals. The investigated molecules (peroxisome proliferator-activated receptors-α and -γ, Toll-like receptor 4, and interleukin-6 and 8) were expressed in almost all skin compartments and exhibited significant aging-associated downregulation in epithelial tissues, mostly in the sebaceous glands, the sweat glands, and the epidermis. With the exception of interleukin-6 in the dermal tissue, no upregulation was detected in the aged group. The results obtained indicate an interesting interaction between different pathways of aging, namely defective stress responses, downregulated innate immunity responses, and activation of the tumorigenesis pathway, which was especially apparent in the sebaceous glands.
Asunto(s)
Inmunidad Innata , Glándulas Sebáceas/inmunología , Envejecimiento de la Piel/inmunología , Piel/química , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Regulación hacia Abajo , Femenino , Humanos , Interleucina-6/análisis , Interleucina-8/análisis , Masculino , Persona de Mediana Edad , PPAR alfa/análisis , PPAR gamma/análisis , Glándulas Sebáceas/química , Receptor Toll-Like 4/análisis , Adulto JovenRESUMEN
BACKGROUND/PURPOSE: The value of psoriatic plaques pretreatment with specific topical preparations in the setting of NB-ultraviolet-B (UVB) therapy is debatable. It may be clarified through a comparative assessment between crude coal tar and petrolatum as pretreatment candidates. METHODS: A prospective study included 40 patients with plaque psoriasis undergoing NB-UVB therapy. We compared among three treatment regimens: NB-UVB alone (control group; n=20) as well as NB-UVB preceded by crude coal tar 3% on one side and petrolatum on the other side (cases group I and II; n=20). Tar and petrolatum were topically applied thrice/day the day before NB-UVB exposure. Applications were removed using olive oil directly before NB-UVB exposure. Regimens' frequency was thrice/week and the clinical outcome was assessed, through both psoriasis area and severity index (PASI) and physician global assessment (PGA) scores, at baseline and 3 months later. RESULTS: There were significant (P<0.01) decreases in both PASI and PGA scores in all the groups. In comparison with the controls, cases revealed significantly (P<0.05) higher improvement percentages in both PASI and PGA scores for both tar and petrolatum. This influence, through the PGA score, was significantly (P<0.05) in favor of petrolatum. CONCLUSION: The pretreatment of psoriatic plaques with either petrolatum or crude coal tar may enhance the therapeutic outcome of NB-UVB, which appeared to favor petrolatum.
Asunto(s)
Alquitrán/administración & dosificación , Emolientes/administración & dosificación , Queratolíticos/administración & dosificación , Vaselina/administración & dosificación , Psoriasis/radioterapia , Terapia Ultravioleta/métodos , Administración Tópica , Adulto , Método Doble Ciego , Femenino , Humanos , Masculino , Estudios Prospectivos , Rayos UltravioletaRESUMEN
The aim of this study was to measure serum interferon-gamma (IFN-gamma) levels in participants with different types and severities of psoriasis. The study was conducted on 21 participants with psoriasis. Participants were divided into 3 groups according to disease severity: erythrodermic, severe plaque, and mild to moderate plaque psoriasis. Fifteen participants received different treatment modalities for 16 weeks and were followed for an additional 12 weeks. The enzyme-linked immunosorbent assay technique was used to measure serum IFN-gamma levels in participants before treatment and compared with matched controls and participants receiving treatment. Significant differences were detected between participants and controls in mean serum IFN-gamma levels before treatment (P<.05). There was a positive correlation between serum IFN-gamma levels and psoriasis area and severity index (PASI) scores, and between serum IFN-gamm levels and clinical type of psoriasis, with the highest serum IFN-gamma levels in the erythrodermic psoriasis group and the lowest in the mild to moderate plaque psoriasis group. Irrespective of the type of treatment, 13 of 15 participants who showed improvement in disease condition with a significant decrease in PASI scores also had a significant decrease in serum IFN-gamma levels (P < .05). Moreover, participants with serum IFN-gamma levels that did not dramatically decrease had a shorter remission period compared with those who showed a significant decrease in serum IFN-gamma levels. The substantial elevation and variation in serum IFN-gamma levels according to disease severity suggest that IFN-gamma has a role in determining disease severity and therapy evaluation, which encourages further research on anti-IFN-gamma biologic therapy in the treatment of psoriasis.